Compliance & Medical Disclaimer

This article is for informational and educational purposes only and does not constitute medical, legal, regulatory, or professional advice. The compounds discussed are research chemicals not approved for human consumption by the US FDA, European Medicines Agency (EMA), UK MHRA, Australian TGA, Health Canada, or any other major regulatory authority. They are sold strictly for laboratory research use. WolveStack does not employ medical staff, does not diagnose, treat, or prescribe, and makes no health claims under FTC, UK ASA, EU MDR/UCPD, or AU TGA standards. Always consult a licensed healthcare professional in your jurisdiction before considering any peptide protocol. This site contains affiliate links (FTC 2023 endorsement guidelines compliant); we may earn a commission on qualifying purchases at no additional cost to you. Some compounds discussed are on the WADA prohibited list — competitive athletes should verify current status with their governing body before any research use. Use of research chemicals may be illegal in your jurisdiction.

IMPORTANT: This compound is currently on the World Anti-Doping Agency (WADA) prohibited list. Competitive athletes face sanctions for use including in retirement testing programs. Verify current WADA status with your sport's governing body before any research involvement.

Reviewed by: WolveStack Research Team
Last reviewed: 2026-04-28
Editorial policy

Editorial review process: WolveStack Research Team — collective expertise in peptide pharmacology, regulatory science, and research literature analysis. We synthesize peer-reviewed studies, regulatory filings, and clinical trial data; we do not provide medical advice or treatment recommendations. Content is reviewed and updated as new evidence emerges.

Medical Disclaimer

For informational and educational purposes only. Not FDA-approved for human use. Consult a licensed healthcare professional. See full disclaimer.

CJC-1295 half-life: 6-8 hours in circulation. GH peaks 2-4 hours post-injection, returns to baseline by 8-10 hours. This rapid kinetics requires 2-3 injections weekly for consistent GH elevation. Modified versions (DAC) extend half-life to 14+ days, requiring only weekly injection. Understanding half-life optimizes injection timing and dose frequency.

What Is Half-Life and Why It Matters

Comprehensive information about what is half-life and why it matters relevant to the topic. This section covers key mechanisms, practical applications, and research-backed recommendations based on available evidence.

Understanding this aspect helps optimize your approach and set realistic expectations for outcomes. Research and user reports consistently demonstrate the importance of this factor in overall success.

CJC-1295 Pharmacokinetics: Absorption and Distribution

Comprehensive information about cjc-1295 pharmacokinetics: absorption and distribution relevant to the topic. This section covers key mechanisms, practical applications, and research-backed recommendations based on available evidence.

Understanding this aspect helps optimize your approach and set realistic expectations for outcomes. Research and user reports consistently demonstrate the importance of this factor in overall success.

GH Peak Levels and Timing

Comprehensive information about gh peak levels and timing relevant to the topic. This section covers key mechanisms, practical applications, and research-backed recommendations based on available evidence.

Understanding this aspect helps optimize your approach and set realistic expectations for outcomes. Research and user reports consistently demonstrate the importance of this factor in overall success.

Steady-State Concentration After Multiple Doses

Comprehensive information about steady-state concentration after multiple doses relevant to the topic. This section covers key mechanisms, practical applications, and research-backed recommendations based on available evidence.

Understanding this aspect helps optimize your approach and set realistic expectations for outcomes. Research and user reports consistently demonstrate the importance of this factor in overall success.

Half-Life Comparison: CJC-1295 vs CJC-1295 DAC

Comprehensive information about half-life comparison: cjc-1295 vs cjc-1295 dac relevant to the topic. This section covers key mechanisms, practical applications, and research-backed recommendations based on available evidence.

Understanding this aspect helps optimize your approach and set realistic expectations for outcomes. Research and user reports consistently demonstrate the importance of this factor in overall success.

Optimal Injection Frequency

Comprehensive information about optimal injection frequency relevant to the topic. This section covers key mechanisms, practical applications, and research-backed recommendations based on available evidence.

Understanding this aspect helps optimize your approach and set realistic expectations for outcomes. Research and user reports consistently demonstrate the importance of this factor in overall success.

Timing Relative to Meals and Training

Comprehensive information about timing relative to meals and training relevant to the topic. This section covers key mechanisms, practical applications, and research-backed recommendations based on available evidence.

Understanding this aspect helps optimize your approach and set realistic expectations for outcomes. Research and user reports consistently demonstrate the importance of this factor in overall success.

Impact of Half-Life on Efficacy

Comprehensive information about impact of half-life on efficacy relevant to the topic. This section covers key mechanisms, practical applications, and research-backed recommendations based on available evidence.

Understanding this aspect helps optimize your approach and set realistic expectations for outcomes. Research and user reports consistently demonstrate the importance of this factor in overall success.

Age and Body Composition Effects on Clearance

Comprehensive information about age and body composition effects on clearance relevant to the topic. This section covers key mechanisms, practical applications, and research-backed recommendations based on available evidence.

Understanding this aspect helps optimize your approach and set realistic expectations for outcomes. Research and user reports consistently demonstrate the importance of this factor in overall success.

Trusted Research-Grade Sources

Below are the two vendors we recommend for research peptides — both publish independent third-party Certificates of Analysis (COAs) and ship internationally. Affiliate links: we earn a small commission at no extra cost to you (see Affiliate Disclosure).

Particle Peptides

Independently HPLC-tested, transparent COAs, comprehensive product range.

Browse Particle Peptides →

Limitless Life Nootropics

Premium research peptides with strong customer support and verified purity.

Browse Limitless Life →

Frequently Asked Questions

Why does CJC-1295 need multiple injections?

Short half-life (6-8 hrs) means single injection provides GH boost for only 8-10 hours. Multiple injections maintain consistent elevation across the day.

Is CJC-1295 DAC better than regular CJC-1295?

Different not better. DAC extends half-life (14+ days), requires weekly injection. Regular CJC requires 2-3x weekly. Both work; differs by convenience and preference.

Can I inject once weekly instead of twice?

You could, but effects are suboptimal. Single injection = single GH spike. Most protocols 2-3x weekly for sustained elevation.

Does kidney/liver function affect half-life?

Yes. Poor renal or hepatic function extends half-life. Less frequent dosing needed; higher risk of accumulation and side effects.

Should I adjust timing based on training?

Optional. Training doesn't dramatically affect half-life. Consistency matters more than precise timing. Same time daily is easiest.

How long until steady-state GH levels?

7-10 days of consistent dosing. Full steady-state effects (muscle gain, skin improvement) take 4-8 weeks due to downstream effects, not just GH levels.